This video explains 10 early signs and symptoms of diabetes that often go unnoticed. These include increased thirst, frequent bathroom breaks, recurrent infections, unexplained weight changes, and blurry…
This video dives into Pompe Disease, also known as Glycogen Storage Disease Type 2. The host explains the key components of this disease, where the body cannot break…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – In most patients who receive drug-eluting stents for unprotected left main disease, restenosis can be managed with a minimally invasive approach, including placement…
NEW YORK (Reuters Health) – Treatment of mild gestational diabetes mellitus (GDM) cut the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders in a study…
NEW YORK (Reuters Health) – Women who become mothers are more likely to develop the metabolic syndrome during middle age than are their nulliparous counterparts, prospective study findings…
NEW YORK (Reuters Health) – Diabetes is an independent risk factor for atrial fibrillation in women, U.S. investigators report in the October issue of Diabetes Care. The disease…
NEW YORK (Reuters Health) – Excessive intake of fructose can increase blood pressure and induce other features of the metabolic syndrome, according to study findings presented Wednesday at…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – When metformin and a sulphonylurea or a glinide fail to bring type 2 diabetes under control, adding pioglitazone may do the trick, French…
